EB - Risk factors of metal health disorders I Flashcards

1
Q

Why do people suffer from neuropsychiatric disorders? (2)

A
  • Risk; involves uncertainty and vulnerability/sensitivity.
  • Genetic factors; a critical determinant.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What genetic models are used for understanding disease risk and why are they useful? (3)

A

Family diagrams:

Family studies

  • Identify families with higher disease incidence.
  • Measure recurrent risk ratio; the increased risk of a disease occurring in a relative of an affected individual compared to the general population

Twin studies

  • MZ vs DZ
  • Higher concordance in monozygotic twins suggests genetic contribution.

Linkage studies:

  • Identify regions of the genome linked to disease inheritance
  • Effective for Mendelian disorders.
  • Less useful for polygenic conditions.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are association studies, and how do they work? (4)

A

Candidate Gene Studies:

  • Focus on specific genes linked to disease.
  • Compare genetic variant frequencies in cases vs. controls.

Genome-Wide Association Studies (GWAS):

  • Scan the genome for disease-linked variants.
  • Effective for common variants with small effects.

Structural Variation Studies:

  • Examine copy number and structural variations.

Sequencing Studies:

  • Detect rare variants with large effects.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are Gene-Environment Interaction (GxE) Studies? (2)

A
  • Study genetic and environmental factor interplay in disease risk.
  • Identify individuals at higher risk based on combined exposures.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are Functional Studies in molecular genetics?

A
  • Explore how genetic variants influence disease mechanisms.
  • Investigate:
    Gene expression.
    Protein function.
    Cellular pathways.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How are Animal Models used in genetic research? (2)

A
  • Study genetic variant effects on disease progression.
  • Example: Use mice to simulate human genetic conditions.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are Clinical Studies, and what do they examine? (4)

A
  • Investigate clinical implications of genetic findings.

Focus areas:

  • Diagnostic test development.
  • Prognostic marker identification.
  • Creation of targeted therapies
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the importance of Pathway Analysis? (2)

A
  • Determines if genetic variants act within the same pathways.
  • Identifies biological pathways influencing disease mechanisms.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the two types of mutations?

A
  • Inherited variations: Passed through generations.
  • De novo mutations: New mutations linked to paternal age.
    The number of de novo mutations in the person’s genome increases with paternal age
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How does the timing of mutations affect cell impact? (5)

A

Parental gonad: All offspring cells affected.
Early embryo: Large proportion affected.
Embryo: A smaller portion of the offspring’s cells will carry the mutation
Fetus: An even smaller portion of the offspring’s cells will carry the mutation.
Post-birth: Tissue-specific effects.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is penetrance in genetics? (3)

A
  • Proportion of individuals with a genetic variant showing the phenotype.
  • Inversely related to allele frequency
  • Example: Huntington’s disease has 100% penetrance with triplet expansion.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is linkage disequilibrium (LD)? (3)

A
  • Non-random association of nearby alleles on a chromosome.

Causes:

  • Genetic Linkage: Close alleles likely inherited together.
  • Population History: Influences LD patterns.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the evidence for heritability? (4)

A

Monozygotic twin studies: Concordance rates for:

  • Autism: 80%–90% (MZ) vs. 5%–15% (DZ).
  • Monozygotic to dizygotic twin concordance ratios for drug addictions are approximately 2:1
  • Psychiatric disorders: Highly polygenic.
  • There are common variants with small effect sizes.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the three groups of genetically related psychiatric disorders identified by GWAS?

A
  • Mood/Psychotic: Depression, bipolar, schizophrenia.
  • Neurodevelopmental: Autism, ADHD, OCD.
  • Compulsive Behaviors: Anorexia, Tourette’s.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are GWAS challenges? (3)

A
  • Sample size; small effect sizes, making them difficult to detect with smaller sample sizes.
  • Sample ancestry; Different populations may have different genetic risk factors
  • Disease definition; a lot of diagnosis is based on self reporting of specific traits
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How does genetic architecture influence psychiatric conditions? (3)

A
  • Common SNPs (≥1% allele frequency).
  • Rare variants (<1% frequency).
  • Structural variations.
17
Q

What is the Genetic Heterogeneity of CNS Disorders? (3)

A
  • No damaging genetic variant appears in more than a few cases.

Analysis focuses on:

  • Identifying trends and commonalities.
  • Studying specific genes/mutations to understand disease biology
18
Q

What genetic associations have GWAS studies revealed about ASD-linked genes? (4)

A
  • Strong associations found with SNPs in genes like NEGR1, PTBP2, CADPS, KCNN2, KMT2E, MACROD2.
  • Genes are Highly expressed in the developing cortex.
  • Genes are Most active prenatally, influencing early brain development.
  • There are genetic correlations with other traits
19
Q

What is Shared Heritability in psychiatric disorders? (2)

A
  • Psychiatric disorders often share genetic and environmental risks.
  • Shared heritability highlights overlapping biological pathways.
20
Q

What are challenges of shared heritability? (2)

A
  • Diagnosing individuals with multiple disorders.
  • Assortative mating, where individuals with similar phenotypes mate.
21
Q

What are Pleiotropic Loci? (3)

A
  • Pleiotropic loci are genetic loci associated with multiple psychiatric disorders.
  • Example: 109 genetic loci linked to shared biology in psychiatric conditions.
  • Suggest potential shared treatment targets
22
Q

What is the role of the DCC Gene in psychiatric disorders? (3)

A
  • DCC Gene Function: Encodes netrin-1 receptor, crucial for axonal growth during neurodevelopment.
  • Suggests axonal disruptions contribute to psychiatric disorder risk.
  • SNP rs8084351 within the DCC gene is linked to eight psychiatric disorders.
23
Q

What is the evolutionary paradox of Schizophrenia and the possible reasons for this phenomenon? (3)

A
  • Despite reduced fecundity (fertility), schizophrenia risk alleles persist.

Possible reasons:

  • Recent Evolution: Some genes associated with schizophrenia are located in regions of the genome that have undergone recent evolutionary changes.
  • Genetic trade-offs, e.g., enhanced creativity or cognition in other contexts (advantagous).
24
Q

What are Human Accelerated Regions (HARs), and their relevance to neuropsychiatric disorders? (3)

A
  • HARs: Genomic regions with rapid evolutionary change in humans.

Linked to:

  • Neural development and SCZ risk.
  • De novo CNVs affecting HARs found in ASD cases.
25
Q

What polymorphisms are associated with Substance Use Disorders (SUDs)? (4)

A
  • OPRM1: µ-opioid receptor, influences opioid dependence and treatment response.
  • ALDH1/2, DRD2, PDE4B: Related to addiction mechanisms.
26
Q

How do Enhancers regulate genes in neurodevelopment? (4)

A

functions:

  • Control pluripotency; ability of a cell to become any type of cell in the body.
  • neuronal differentiation.
  • neuronal development
  • adult neuron function.

Note: Majority of SNPs are outside genes – may affect regulatory regions e.g. enhancers